LBLeón Alberto Bouvier

León Alberto Bouvier

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


León Alberto Bouvier has a total of 25 co-authors. Here are the top co-authors by number of shared publications:

  • Claudio Alejandro Pereira

    Universidad de Buenos Aires, Facultad de Medicina, Instituto de Investigaciones Médicas A. Lanari, Buenos Aires, Argentina; Consejo Nacional de Investigaciones Científicas y Técnicas, Universidad de Buenos Aires, Instituto de Investigaciones Médicas (IDIM), Laboratorio de Parasitología Molecular, Buenos Aires, Argentina

    4 shared publications
  • Gaspar E. Canepa

    Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD 20852

    3 shared publications
  • Mariana R Miranda

    2 shared publications
  • Ariel Mariano Silber

    Laboratory of Biochemistry of Tryps - LaBTryps, Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo, Brazil

    1 shared publication
  • Carolina Carrillo

    Laboratorio de Parasitología Molecular y Bioquímica, Instituto de Ciencia y Tecnología Dr. Cesar Milstein, Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET). Saladillo, (C1440FFX) Ciudad Autónoma de Buenos Aires, Argentina

    1 shared publication
  • Fabio A Digirolamo

    Laboratorio de Biología Molecular de Trypanosoma cruzi, Instituto de Investigaciones Médicas Alfredo Lanari, Buenos Aires

    1 shared publication

Latest Publications

  • Open Access

    A versatile 2A peptide-based strategy for ectopic expression and endogenous gene tagging in Trypanosoma cruzi

    by Gabriela T. Niemirowicz, Giannina Carlevaro, Oscar Campetella, León A. Bouvier, Juan Mucci


  • Open Access

    DNA Damage-Induced RNAPII Degradation and Its Consequences in Gene Expression

    by Juan Cristobal Muñoz, Inés Beckerman, Ramveer Choudhary, León Alberto Bouvier, Manuel J. Muñoz

    RPB1, the major and catalytic subunit of human RNA Polymerase II (RNAPII), is specifically degraded by the ubiquitin–proteasome system upon induction of DNA damage by different agents, such as ultraviolet (UV) light. The “last resort” model of RNAPII degradation states that a persistently stalled RNAPII is degraded at the site of the DNA lesion in order to facilitate access to Nucleotide Excision Repair (NER) factors, thereby promoting repair in template strands of active genes. Recent identification and mutation of the lysine residue involved in RPB1 ubiquitylation and degradation unveiled the relevance of RNAPII levels in the control of gene expression. Inhibition of RNAPII degradation after UV light exposure enhanced RNAPII loading onto chromatin, demonstrating that the mere concentration of RNAPII shapes the gene expression response. In this review, we discuss the role of RNAPII ubiquitylation in NER-dependent repair, recent advances in RPB1 degradation mechanisms and its consequences in gene expression under stress, both in normal and repair deficient cells.


  • Open Access

    Simplified inducible system for Trypanosoma brucei

    by Gabriela T Niemirowicz, Juan J Cazzulo, Vanina E Álvarez, León A Bouvier

    Nowadays, most reverse genetics approaches in Trypanosoma brucei, a protozoan parasite of medical and veterinary importance, rely on pre-established cell lines. Consequently, inducible experimentation is reduced to a few laboratory strains. Here we described a new transgene expression system based exclusively on endogenous transcription activities and a minimum set of regulatory components that can easily been adapted to different strains. The pTbFIX vectors are designed to contain the sequence of interest under the control of an inducible rRNA promoter along with a constitutive dicistronic unit encoding a nucleus targeted tetracycline repressor and puromycin resistance genes in a tandem “head-to-tail” configuration. Upon doxycycline induction, the system supports regulatable GFP expression (170 to 400 fold) in both bloodstream and procyclic T. brucei forms. Furthermore we have adapted the pTbFIX plasmid to perform RNAi experimentation. Lethal phenotypes, including α-tubulin and those corresponding to the enolase and clathrin heavy chain genes, were successfully recapitulated in procyclic and bloodstream parasites thus showing the versatility of this new tool.


  • Open Access

    Plasmid Vectors and Molecular Building Blocks for the Development of Genetic Manipulation Tools for Trypanosoma cruzi

    by León A. Bouvier, María de Los Milagros Cámara, Gaspar E. Canepa, Mariana R. Miranda, Claudio A. Pereira

    The post genomic era revealed the need for developing better performing, easier to use and more sophisticated genetic manipulation tools for the study of Trypanosoma cruzi, the etiological agent of Chagas disease. In this work a series of plasmids that allow genetic manipulation of this protozoan parasite were developed. First of all we focused on useful tools to establish selection strategies for different strains and which can be employed as expression vectors. On the other hand molecular building blocks in the form of diverse selectable markers, modifiable fluorescent protein and epitope-tag coding sequences were produced. Both types of modules were harboured in backbone molecules conceived to offer multiple construction and sub-cloning strategies. These can be used to confer new properties to already available genetic manipulation tools or as starting points for whole novel designs. The performance of each plasmid and building block was determined independently. For illustration purposes, some simple direct practical applications were conducted.


    • 1 January 2012
      • Vol. 72  (3) , 221-6

    [The mammalian TOR pathway is present in Trypanosoma cruzi. In silico reconstruction and possible functions].

    by Fabio A Digirolamo, Mariana R Miranda, León A Bouvier, María M Cámara, Gaspar E Cánepa, Claudio A Pereira

    The mammalian TOR pathway ("Target Of Rapamycin") is a regulatory protein network involved in a wide range of processes including cell growth and differentiation, providing a functional switch between anabolic and catabolic cell metabolism. Trypanosoma cruzi, the etiologic agent of Chagas disease, has a complex life cycle with different morphological stages in various hosts. This life cycle implies that parasites have to deal with fluctuations in the extracellular medium that should be detected and counteracted adapting their metabolism. A candidate to be the mediator between the receptors / sensors of the environment and cellular adaptive response is the TOR pathway. In this paper we integrate the bibliographic data of the TOR pathway in trypanosomatids by in silico analysis (computer simulation of biological structures and processes) of the parasite's genome. Possible effectors and processes regulated by this metabolic pathway are also proposed. Given that the information on the mechanisms of signal transduction in trypanosomatids is scarce, we consider the model presented in this work may be a reference for future experimental work.


    • 1 January 2008
      • Vol. 68  (5) , 398-404

    [Trypanosoma cruzi: transport of essential metabolites acquired from the host].

    by Claudio A Pereira, Carolina Carrillo, Mariana R Miranda, León A Bouvier, Gaspar E Cánepa

    Trypanosoma cruzi is the etiological agent of Chagas disease, a disease endemic not only in Argentina but also in all of Latin America. T. cruzi presents several metabolic characteristics which are completely absent in its insect vectors and in mammalian hosts. Some of these differences were acquired after millions of years of adaptation to parasitism, during which this protozoan replaced many biosynthetic routes for transport systems. In the present review, we describe the advances in the knowledge of T. cruzi transport processes and the molecules involved. In particular, we focus on amino acid and polyamine transporters from the AAAP family (Amino Acid/Auxin Permeases), because they seem to be exclusive transporters from trypanosomatids. Taking into account that these permeases are completely absent in mammals, they could be considered as a potential target against Trypanosoma cruzi.


  • Arginine metabolism in Trypanosoma cruzi is coupled to parasite stage and replication

    by Claudio A Pereira, Guillermo D Alonso, Soledad Ivaldi, Ariel Silber, Maria Júlia M Alves, León A Bouvier, Mirtha M Flawiá, Héctor N Torres

    L‐Arginine plays an essential role in the energetic metabolism of Trypanosoma cruzi. In this work we propose a relationship between L‐arginine uptake, arginine kinase activity and the parasite replication ability. In epimastigote cultures L‐arginine uptake decreases continuously accompanying a cell replication rate reduction. The use of conditioned or fresh medium mimics uptake variations. Interestingly, in non‐replicative trypomastigote cells, L‐arginine uptake was undetectable. The association between L‐arginine uptake and cell replication was demonstrated using the antimitotic agent hydroxyurea. Arginine kinase, the enzyme responsible for phosphoarginine and ATP synthesis, also shows a differential activity in epimastigote and trypomastigote parasite stages.